(PDF) Rapamycin Enhances the Sensitivity of ER‑positive

Rapamycin Enhances the Sensitivity of ER‑positive Breast Cancer Cells to Tamoxifen by Upregulating P73 Expression

Oncology Reports - Greece

doi 10.3892/or.2018.6842

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

November 1, 2018

Authors

Tian‑Song Xia

Publisher

Spandidos Publications

Related search

Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age

Advances in Therapy

English

The mTOR Inhibitor Rapamycin Synergizes With a Fatty Acid Synthase Inhibitor to Induce Cytotoxicity in ER/HER2-Positive Breast Cancer Cells

Multidisciplinary

English

PKA-induced Phosphorylation of ERα at Serine 305 and High PAK1 Levels Is Associated With Sensitivity to Tamoxifen in ER-positive Breast Cancer

Breast Cancer Research and Treatment

Cancer Research

English

miR-375 Inhibits Cancer Stem Cell Phenotype and Tamoxifen Resistance by Degrading HOXB3 in Human ER-positive Breast Cancer

Oncology Reports

Cancer Research

English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research

Cancer Research

English

Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research

Cancer Research

English

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells

Multidisciplinary

English

ERK/MAPK Regulates ERRγ Expression, Transcriptional Activity and Receptor-Mediated Tamoxifen Resistance in ER+ Breast Cancer

Molecular Biology

English

Progesterone Enhances Calcitriol Antitumor Activity by Upregulating Vitamin D Receptor Expression and Promoting Apoptosis in Endometrial Cancer Cells

Cancer Prevention Research

Cancer Research

English